Sascha Braun

Dr. Sascha Braun is a Researcher in the Optical Molecular Diagnostics and System Technology Department at the Leibniz Institute of Photonic Technology (Leibniz-IPHT) in Jena, Germany. Their work focuses on developing advanced molecular diagnostic tools for pathogen detection and characterization, with particular expertise in bacterial genomics and antimicrobial resistance mechanisms.

Dr. Braun's research interests span multiple critical areas in modern microbiology and diagnostics. Their work in molecular diagnostics includes developing protein microarrays for pathogen serotyping and lyophilized qPCR assays for antibiotic resistance gene detection. In bacterial genomics, they investigate Staphylococcus species diversity, particularly S. aureus lineages across different hosts and geographical regions including Rwanda and the UAE. Their bioinformatics contributions include tools like AssayBLAST and ConsensusPrime for molecular assay design and validation. Dr. Braun also explores One Health connections between human and animal pathogens, demonstrating how human-associated S. aureus lineages colonize companion animals and livestock.

Dr. Braun's publication record shows a strong focus on practical diagnostic solutions with immediate clinical and public health applications. Their work on Oxford Nanopore sequencing addresses critical limitations in bacterial outbreak tracing, while their development of lyophilized qPCR assays targets resource-limited settings. The research demonstrates consistent collaboration with experts in microbiology, bioinformatics, and veterinary medicine, reflecting an interdisciplinary approach to pathogen detection and characterization.

Dr. Braun actively contributes to the scientific community through numerous peer-reviewed publications in high-impact journals including Toxins, International Journal of Molecular Sciences, and Genome Research. Their work has practical implications for clinical diagnostics, food safety, and public health surveillance systems worldwide.

As part of the Leibniz-IPHT research team, Dr. Braun collaborates extensively with colleagues including Ralf Ehricht, Stefan Monecke, and Elke Müller on projects spanning molecular assay development, pathogen characterization, and diagnostic technology innovation. Their research has particular relevance to global health challenges including antimicrobial resistance and zoonotic disease transmission.